1. Home
  2. NRSN vs SGMA Comparison

NRSN vs SGMA Comparison

Compare NRSN & SGMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • SGMA
  • Stock Information
  • Founded
  • NRSN 2017
  • SGMA 1993
  • Country
  • NRSN Israel
  • SGMA United States
  • Employees
  • NRSN N/A
  • SGMA N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • SGMA Electrical Products
  • Sector
  • NRSN Health Care
  • SGMA Technology
  • Exchange
  • NRSN Nasdaq
  • SGMA Nasdaq
  • Market Cap
  • NRSN 17.8M
  • SGMA 16.3M
  • IPO Year
  • NRSN 2021
  • SGMA 1994
  • Fundamental
  • Price
  • NRSN $1.14
  • SGMA $1.59
  • Analyst Decision
  • NRSN Hold
  • SGMA
  • Analyst Count
  • NRSN 1
  • SGMA 0
  • Target Price
  • NRSN N/A
  • SGMA N/A
  • AVG Volume (30 Days)
  • NRSN 360.5K
  • SGMA 73.1K
  • Earning Date
  • NRSN 12-31-2024
  • SGMA 12-24-2024
  • Dividend Yield
  • NRSN N/A
  • SGMA N/A
  • EPS Growth
  • NRSN N/A
  • SGMA N/A
  • EPS
  • NRSN N/A
  • SGMA N/A
  • Revenue
  • NRSN N/A
  • SGMA $360,530,443.00
  • Revenue This Year
  • NRSN N/A
  • SGMA N/A
  • Revenue Next Year
  • NRSN N/A
  • SGMA N/A
  • P/E Ratio
  • NRSN N/A
  • SGMA N/A
  • Revenue Growth
  • NRSN N/A
  • SGMA N/A
  • 52 Week Low
  • NRSN $0.51
  • SGMA $1.50
  • 52 Week High
  • NRSN $2.33
  • SGMA $6.47
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 56.63
  • SGMA 21.10
  • Support Level
  • NRSN $0.80
  • SGMA $2.03
  • Resistance Level
  • NRSN $1.29
  • SGMA $2.58
  • Average True Range (ATR)
  • NRSN 0.13
  • SGMA 0.18
  • MACD
  • NRSN 0.01
  • SGMA -0.09
  • Stochastic Oscillator
  • NRSN 68.75
  • SGMA 8.27

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About SGMA SigmaTron International Inc.

Sigmatron International Inc is an independent provider of electronic manufacturing services (EMS). It provides manufacturing and assembly services ranging from the assembly of individual components to the assembly and testing of box-build electronic products. The company manufactures products like printed circuit board assemblies, electro-mechanical subassemblies, and completely assembled (box-build) electronic products which are incorporated into finished products and sold in various industries, particularly industrial electronics, consumer electronics, and life sciences. In some instances, it manufactures and assembles the completed finished product for its customers. Geographically, the company derives maximum revenue from Mexico and the rest from the United States, China, and Vietnam.

Share on Social Networks: